Marc Kubasak
Marc is a highly accomplished executive in the pharmaceutical industry, bringing extensive experience across all phases of drug development, multiple therapeutic areas, and various drug modalities. With nearly two decades in drug development, Marc has successfully led or overseen global regulatory submissions, health authority meetings, and obtained marketing application approvals in all major markets. Marc spent 15 years at Amgen holding various leadership positions in Regulatory Affairs and Program Leadership. Following Amgen, Marc joined a startup biotechnology company as employee number eight heading Regulatory Affairs and Program Leadership where he built high performing teams supporting multiple acquisitions and an initial public offering. Exposure to both large and startup biotechnology companies has provided Marc with a unique and valuable combination of skills and experiences. Those experiences include rare diseases, large outcomes studies, combination products, and multiple Advisory Committee Meetings with the FDA. Marc’s passion for developing innovative and impactful treatments to meet the unmet needs of patients made him a welcomed addition to Dompe.Marc holds both an MS in Physiological Science and a PhD in Molecular, Cellular, and Integrative Physiology from the University of California, Los Angeles. In his free time, he enjoys staying active, traveling, and spending time with his family and friends.